Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +200.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +161.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +55665 basis points from the comparable as-filed period.
Revenue changed +88.4% from the comparable as-filed period.
Cash & equivalents changed +193.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross margin changed -3801 basis points from the comparable as-filed period.
Free-cash-flow proxy changed +17.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current assets changed -42.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed -134.4% from the comparable as-filed period.
Total assets changed -41.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash flow changed +17.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Shares outstanding changed +28.6% from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
Cost of revenue changed +116.4% from the comparable as-filed period.
Stock-based compensation changed +135.0% from the comparable as-filed period.
Operating income changed -9.6% from the comparable as-filed period.
Working capital / assets changed -8368 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
SBC / revenue changed +3146 basis points from the comparable as-filed period.
Current liabilities changed -23.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Receivables / revenue changed +6353 basis points from the comparable as-filed period.
Current ratio changed -24.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed -15.2% from the comparable as-filed period.
Free-cash-flow margin changed +83028 basis points from the comparable as-filed period.
Operating cash-flow margin changed +83143 basis points from the comparable as-filed period.
R&D / revenue changed -13549 basis points from the comparable as-filed period.
Working capital changed +12.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed +115 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.